Morning Briefing
Summaries of health policy coverage from major news organizations
Abbott Agrees To $1.6B Settlement With States, Feds
Abbott Laboratories will pay the federal government and 45 states $1.6 billion after admitting to marketing its anti-seizure drug Depakote for off-label uses over 10 years.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
